ngrunes

Mannkind: Overlooked Biotech With Excellent Prospects (Part I)

Mannkind's 10K compares "Post-meal insulin levels in healthy subjects" with "Post-meal insulin levels with Technosphere Insulin in patients with type 2 diabetes": "This [graphical] comparison illustrates the degree to which our Technosphere System approximates the insulin profile of healthy individuals following meal onset."

But it appears to do nothing of the sort. The first graph peaks at 60 minutes, whereas TI appears to peak within 15. Scales of the two graphs are even dissimilar. Does anyone actually read the 10K? What am I missing in this graphical comparison?